⌕
Takeda Pharmaceutical · TAK · NYSE
Tenet 32 · Weak
Compare
$21.59+0.75%At closeTenet 32 · Weak
$21.59+0.16 (+0.75%)
At close: Nov 16, 2026, 4:00 PM ET· NYSE · USD

Takeda Pharmaceutical (TAK) Institutional Ownership

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice

5 figures withheld by our checks. Each blank figure names its reason.

13F fund flowQuarter ended Jun 30, 2026. Withheld: many filers have already reported a later quarter, so their changes in this quarter are not on file and the counts of new, added, trimmed and closed positions are not shown. These positions are 140 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
SHARES HELD BY 13F FILERS
withheld
withheld by our checks · 386 filers, Jun 30, 2026
# 13F FUNDS
386
13F VALUE
$1.7B
106.0M shares
Withheld: 13F filers report depositary receipts and the company reports ordinary shares, so the two do not divide.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Nov 4, 2026Platford Giles RichardPresident, IBUDisposed · Open-market sale55,617American Depositary Shares$20.90↗
Nov 2, 2026Bitetti Teresa MariePresident, OBUDisposed · Open-market sale46,609American Depositary Shares$20.89↗
Sep 14, 2026Duprey Lauren RusckowskiChief Transformation OfficerDisposed · Open-market sale34,535American Depositary Shares$18.54↗
Sep 2, 2026Plump Andrew StewartPresident, R&DDisposed · Open-market sale116,191American Depositary Shares$18.49↗
Aug 19, 2026Plump Andrew StewartPresident, R&DDisposed · Open-market sale19,651American Depositary Shares$18.49↗
Aug 18, 2026Greenway Nicola Deidre PetalChief Human Resources OfficerDisposed · Open-market sale12,980American Depositary Shares$18.11↗
Aug 11, 2026Shannon Elaine MaryPres., Global Supply & QualityDisposed · Open-market sale20,363American Depositary Shares$17.55↗
Aug 10, 2026Farajallah Awny Samaan BotrosChief Medical OfficerDisposed · Open-market sale14,006American Depositary Shares$17.10↗
Aug 10, 2026Ibrahim Ramy Riad AhmedPresident, PDT BUDisposed · Open-market sale7,277American Depositary Shares$17.10↗
Aug 10, 2026Pacheco Rhonda JanicePresident, U.S. Business UnitDisposed · Open-market sale16,901American Depositary Shares$17.10↗
Aug 10, 2026Duprey Lauren RusckowskiChief Transformation OfficerDisposed · Open-market sale47,586American Depositary Shares$17.10↗
Aug 10, 2026Plump Andrew StewartPresident, R&DDisposed · Open-market sale165,393American Depositary Shares$17.10↗
Aug 10, 2026Pignagnoli Agosti MarcelloHead, Strat. & Port. DevDisposed · Open-market sale22,957American Depositary Shares$17.10↗
Aug 10, 2026Bitetti Teresa MariePresident, OBUDisposed · Open-market sale50,012American Depositary Shares$17.10↗
Aug 10, 2026Shannon Elaine MaryPres., Global Supply & QualityDisposed · Open-market sale3,978American Depositary Shares$17.10↗
Aug 10, 2026Ricci GabrieleChief Data & Tech. OfficerDisposed · Open-market sale25,088American Depositary Shares$17.10↗
Aug 10, 2026Greenway Nicola Deidre PetalChief Human Resources OfficerDisposed · Open-market sale6,774American Depositary Shares$17.10↗
Aug 10, 2026Kim Julie So-YoungPresident and CEODisposed · Open-market sale89,090American Depositary Shares$17.10↗
Aug 10, 2026Platford Giles RichardPresident, IBUDisposed · Open-market sale31,083American Depositary Shares$17.10↗
Aug 10, 2026Furney Natalie Anne MarieGlobal General CounselDisposed · Open-market sale30,868American Depositary Shares$17.10↗

* Holdings as reported for Jun 30, 2026, 140 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How many 13F filers hold Takeda Pharmaceutical?

Takeda Pharmaceutical was held by 386 13F filers as of Jun 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.